1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
(
- Contribution to journal › Letter
-
Mark
Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state
(
- Contribution to journal › Article
- 2024
-
Mark
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
(
- Contribution to journal › Article
-
Mark
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)
2024) In Leukemia(
- Contribution to journal › Article
-
Mark
Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction
(
- Contribution to journal › Letter
-
Mark
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults—a BMTSS report
(
- Contribution to journal › Article
-
Mark
Hairy cell leukemia variant and WHO classification correspondence Re : 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression
(
- Contribution to journal › Letter
-
Mark
A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia
(
- Contribution to journal › Article